Apotex, the largest Canadian based pharmaceutical company, and Cumberland Pharmaceuticals Inc. (“Cumberland”), a U.S. based specialty pharmaceutical company, announce that they have entered into a strategic transaction to integrate Cumberland’s U.S. branded businesses into Apotex (the “Transaction”). Under the terms of the agreement, Apotex will add a portfolio of branded medicines to its US business. The Transaction is expected to significantly expand Apotex’s U.S. specialty and hospital focused business with a diversified basket of products across acute care, oncology, infectious disease, and gastroenterology.
Read the full article: Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate Their U.S. Branded Businesses //
Source: https://www.prnewswire.com/news-releases/apotex-announces-strategic-transaction-with-cumberland-pharmaceuticals-to-integrate-their-us-branded-businesses-302751213.html